| Unravelling the collateral damage of antibiotics on gut bacteria L Maier, CV Goemans, J Wirbel, M Kuhn, C Eberl, M Pruteanu, P Müller, ... Nature 599 (7883), 120-124, 2021 | 274 | 2021 |
| High-throughput anaerobic screening for identifying compounds acting against gut bacteria in monocultures or communities P Müller, J de la Cuesta-Zuluaga, M Kuhn, M Baghai Arassi, T Treis, ... Nature Protocols 19 (3), 668-699, 2024 | 14 | 2024 |
| Comprehensive analysis of human cytomegalovirus-and HIV-mediated plasma membrane remodeling in macrophages R Businger, S Kivimäki, S Simeonov, G Vavouras Syrigos, J Pohlmann, ... Mbio 12 (4), 10.1128/mbio. 01770-21, 2021 | 7 | 2021 |
| Non-antibiotic drugs break colonization resistance against pathogenic Gammaproteobacteria A Grießhammer, J de la Cuesta-Zuluaga, T Zahir, P Müller, C Gekeler, ... bioRxiv, 2023.11. 06.564936, 2023 | 5 | 2023 |
| Proton-pump inhibitors increase C. difficile infection risk by altering pH rather than by affecting the gut microbiome based on a bioreactor model J Schumacher, P Mueller, J Sulzer, F Faber, B Molitor, L Maier bioRxiv, 2024.07. 10.602898, 2024 | 1 | 2024 |
| Balancing act: counteracting adverse drug effects on the microbiome J de la Cuesta-Zuluaga, P Müller, L Maier Trends in Microbiology, 2024 | | 2024 |
